Latest News “Nature Biotechnology: COVID-19 long haulers” Click here. “Ampio gets promising data on drug that could be used to treat COVID” Click here. Ampio Pharmaceuticals, Inc. to Join the Russell 2000® Index and Russell 3000® IndexDate: June 18, 2021 | READ MORE > Ampio Provides Update on Osteoarthritis of the Knee (OAK) Program, Reiterates Compelling Data in Earlier Phase III Trials of Ampion in Severe OAKDate: June 17, 2021 | READ MORE > Ampio Pharmaceuticals Receives Approval to Expand Enrollment of its AP-019 Phase II Study to IndiaDate: June 15, 2021 | READ MORE > Ampio Pharmaceuticals to Participate in the Alliance Global Partners’ Virtual Summer Healthcare SymposiumDate: June 14, 2021 | READ MORE > Ampio Pharmaceuticals to Present at the 2021 International Society for Pharmaceutical Engineers Annual Meeting and ExpoDate: June 14, 2021 | READ MORE > Ampio Pharmaceuticals to Present Poster at the International Society for Aerosols in Medicine (ISAM) 23rd International CongressDate: May 21, 2021 | READ MORE > Ampio Pharmaceuticals Receives Investigational Review Board Approval for its Phase I Long COVID-19 Trial (AP-018)Date: May 10, 2021 | READ MORE > Ampio Pharmaceuticals, Inc. Reports First Quarter 2021 Financial Results and Provides Business UpdateDate: May 5, 2021 | READ MORE > Ampion™ Reduces All-cause Mortality in COVID-19 Respiratory Distress by Nearly 80%Date: April 27, 2021 | READ MORE > Ampio Pharmaceuticals Provides Updates on Clinical Programs for Ampion™ in Osteoarthritis and COVID-19Date: April 27, 2021 | READ MORE > Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business UpdateDate: April 21, 2021 | READ MORE > Research Shows Ampion™ Gene Regulation Mimics the Anti-Inflammatory Effects of Steroids, but without Adverse EffectsDate: April 19, 2021 | READ MORE > Ampio Pharmaceuticals’ Study Shows Ampion Inhibits a Key Inflammatory Pathway in COVID-19 and Lupus NephritisDate: April 6, 2021 | READ MORE > Ampio Pharmaceuticals to Present at the International Society for Aerosols in Medicine (ISAM) 23rd International CongressDate: March 29, 2021 | READ MORE > Ampio Pharmaceuticals to Present at Benzinga Biotech Small Cap ConferenceDate: March 19, 2021 | READ MORE > Ampio Pharmaceuticals Details Early Positive Results for Inhaled Ampion in COVID-19 Respiratory DistressDate: March 16, 2021 | READ MORE > Ampio Pharmaceuticals to Participate in the 33rd Annual Virtual ROTH Conference on March 15-17, 2021Date: March 10, 2021 | READ MORE > Ampio Pharmaceuticals, Inc. Reports Fourth Quarter 2020 Financial Results and Provides Business UpdateDate: March 3, 2021 | READ MORE > Ampio Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences ConferenceDate: March 3, 2021 | READ MORE > Ampio Pharmaceuticals, Inc. to Report Annual 2020 Financial Results and Provide Corporate Business UpdateDate: February 24, 2021 | READ MORE >
